V600-mutated BRAF Unresectable Melanoma
1 clinical trials · Condition
◉ Watch V600-mutated BRAF Unresectable Melanoma
| Record | Firm | Date |
|---|---|---|
| A Phase 1b Open Label, Dose Escalation Study of PLX3397 in Combination With Vemurafenib in V600-mutated BRAF Melanoma (NCT01826448) | Daiichi Sankyo | 2013-11-05 |
Track V600-mutated BRAF Unresectable Melanoma automatically
Every clearance here is in the API, with alerts when new ones post.